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Abstract
Rationale: Unbiased approaches that study aberrant protein expression in primary airway epithelial cells at single cell level
may profoundly improve diagnosis and understanding of airway diseases. We here present a flow cytometric procedure to
study CFTR expression in human primary nasal epithelial cells from patients with Cystic Fibrosis (CF). Our novel approach
may be important in monitoring of therapeutic responses, and better understanding of CF disease at the molecular level.
Objectives: Validation of a panel of CFTR-directed monoclonal antibodies for flow cytometry and CFTR expression analysis
in nasal epithelial cells from healthy controls and CF patients.
Methods: We analyzed CFTR expression in primary nasal epithelial cells at single cell level using flow cytometry. Nasal cells
were stained for pan-Cytokeratin, E cadherin, and CD45 (to discriminate epithelial cells and leukocytes) in combination with
intracellular staining of CFTR. Healthy individuals and CF patients were compared.
Measurements and Main Results: We observed various cellular populations present in nasal brushings that expressed CFTR
protein at different levels. Our data indicated that CF patients homozygous for F508del express varying levels of CFTR
protein in nasal epithelial cells, although at a lower level than healthy controls.
Conclusion: CFTR protein is expressed in CF patients harboring F508del mutations but at lower levels than in healthy
controls. Multicolor flow cytometry of nasal cells is a relatively simple procedure to analyze the composition of cellular
subpopulations and protein expression at single cell level.
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Introduction
Quantitative protein analysis at single cell level is critically
important to study cell-type specific regulation of protein function
in health and disease but limited techniques are available to
perform single cell analysis in primary patient material [1,2]. Flow
cytometry has been widely used in immunology to study protein
expression at single cell level of haematopoietic cells. The
application of flow cytometry for other tissues is hampered by
the ability to generate single cell suspensions, and the accessibility
of patient samples.
Cystic fibrosis (CF) is caused by mutations of the gene encoding
for Cystic Fibrosis transmembrane conductance regulator (CFTR)
[3–5]. CF affects multiple organs but morbidity and mortality is
dominated by CF lung disease that is characterized by mucus
plugging, airway infections and sustained inflammation [6]. The
most common mutation encodes for a CFTR protein that lacks
phenylalanine at position 508 (F508del CFTR) causing it to misfold
and retain in the endoplasmic reticulum from where is degraded
[7,8]. Contrasting data has been published on F508del CFTR
protein expression levels in native airway epithelial cells. Ka ¨lin et al.
showed endogenous wild type (wt) and F508del CFTR at similar
intensity levels as healthy controls at the apical membrane in
epithelial from nasal polyps [9]. This is in accordance with a study
published by Penque et al. who observed apical CFTR in nasal
epithelial cells from homozygous F508del patients, although it was
found that the percentage of CFTR positive cells were significantly
lower [10]. In addition Borthwick et al. recently reported similar
CFTR expression at the apical surface between non-CF and CF
cells in bronchial epithelium, although in CF cells the amount of
CFTR expression was reduced [11]. However, Kreda et al. could
not detect F508del CFTR at the apical membrane, and reported
that the immature form of CFTR that resides in the ER was present
at much lower levels [12,13]. So quantification of CFTR protein
expression has been proven difficult and it remains unclear whether
differences in CFTR expression levels of individual patients can be
related to residual function and CF disease variability in subjects
harboring similar CFTR mutations.
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 12 | e27658Here, we developed a novel unbiased procedure to study CFTR
expression in primary epithelial cells isolated from the nasal cavity
at the single cell level by flow cytometry. CFTR function
measurements in nasal epithelium correlate with CF disease
indicating that nasal epithelium is a relevant tissue for studying CF
disease mechanisms [14]. Nasal epithelial cells were harvested by a
relatively non-invasive simple procedure. We validated this
technique using other previously described techniques including
Western blot analysis and RT-PCR. With this procedure we were
able to study CFTR expression in nasal epithelial cells with a
variety of CFTR antibodies, and found F508del homozygous
patients to express CFTR protein, but at a lower level compared to
healthy controls.
Results
Validation of CFTR expression in primary human
epithelial cells
Since CFTR expression analysis by Westernblot incells obtained
from the nasal cavity by brushing is difficult due to contaminating
cells and low cell yield we developed a novel assay to study CFTR
protein level in individual nasal epithelial cells. However, we first
validated that cells isolated by nasal brushing expressed CFTR as
has been shown by others [10,15,16]. As expected, we observed
CFTR mRNA expression in nasal cells obtained from two healthy
individuals as indicated by RT-PCR (Fig. 1A). Calu-3 cells served as
positive control and b2M was amplified as control for cDNA input.
To assess CFTR protein expression in cells obtained from the nasal
cavity, we pooled samples of multiple healthy individuals and
performed Western blot analysis. We observed immunoreactivity
around 170 kDa and to a lesser extent around 150 kDa in nasal
cells and Calu-3 cells that co-migrated with ectopic CFTR
expressed by BHK cells (Fig. 1B). This suggests that nasal cells
collected by brushing expressed the fully glycosylated mature form
(band C) and the immature form (band B) of CFTR. Together,
these data demonstrate that our nasal brushings contained CFTR-
expressing cells.
Differentiation of nasal brushing cells by flow cytometry
We next analyzed the yield and composition of cells isolated by
brushing using flow cytometry. Single cell suspensions were
generated by resuspending brushed cells in ice cold PBS
containing EDTA and removing remaining cell clumps by passing
cells through a 50 mM filter. Forward and side scatter (FSC and
SSC) analysis by flow cytometry revealed a population of cells
(gated in Fig. 2A) that was negative for propidium iodide (data not
shown). To determine the cellular composition within this gated
population, cells were stained intracellular for the epithelial
markers pan-Cytokeratin and E cadherin or the haematopoietic
marker CD45 (Fig. 2B). We could clearly distinguish E cadherin
and pan-Cytokeratin double positive cells from CD45-expressing
haematopoeitic cells that displayed a relative confined FSC/SSC
profile. Considerable variation in cellular yield (counted using
flowcount beads and indicated by blue events in the left panel of
Fig. 2A) and composition was obtained between brushings
(Fig. 2C). Gated events varied between 0.16 and 1.1610
6 events
per brushing, and consisted of approximately 30% of total events.
Within this gate, approximately 50% of cells expressed epithelial
markers. In conclusion, these data indicate that epithelial cells
from nasal brushings could be separated into single cell
suspensions and distinguished from leucocytes using pan-Cytoker-
atin or E cadherin as marker by flow cytometry.
Validation of CFTR antibodies for flow cytometry in cell
lines
To demonstrate the capacity of various CFTR-directed
monoclonal antibodies to recognize CFTR by flow cytometry,
we used an identical procedure to process cell lines stably
expressing human CFTR or non-transfected control cells.
Intracellular staining for CFTR was performed using mAb 24.1,
M3A7, L12B4, 217, 432, 450, 570, 596, and 769 on CFTR-BHK
cells and non-transfected control cells. CFTR expression was
indicated by mean fluorescence intensity (MFI) and CFTR-BHK
cells were compared to non-transfected BHK cells for four
different dilutions of the mAb. CFTR-specific detection was
observed for mIgG1 432, 450, 570 and 769, mIgG2a 24.1 and
mIgG2b 596 and only limited for mIgG1 M3A7. For mAbs 217
(mIgG1) and L12B4 (mIgG2a) high background levels were
detected in non-transfected BHK and only a modest fluorescent
increase was detected in CFTR-BHK cells. For L12B4 specific
detection of CFTR was observed upon transient transfection of
hCFTR in HEK293 cells, in contrast to mAb 217. We further
confirmed specific detection of CFTR by mAb 450 in CFBE41o¯
cells transduced with wt-CFTR or F508del-CFTR.
Knockdown of CFTR by siRNA in CFBE abolished CFTR
detection both by flow cytometry and Western blot analysis
Figure 1. CFTR expression in cells obtained by nasal brushing. A. Quantitative real-time PCR analysis for CFTR and b2-microglobulin in nasal
cells obtained from two healthy donors. Calu-3 cells were used as positive control. B. Western blot analysis of CFTR in brushed nasal cells. CFTR
protein was detected as a mature form (c) and an immature form (b) with anti-CFTR mAb 24.1. Anti-EGF receptor was used as control.
doi:10.1371/journal.pone.0027658.g001
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769 (see Figure S1). Together, these data indicate that ectopically
expressed CFTR can be detected by flow cytometry using mAbs
432, 450, 570, 596, 769, L12B4 and 24.1 and only limited for
mAb 217.
CFTR detection in human nasal epithelial cells by flow
cytometry
Subsequently, we studied CFTR expression by multi-color flow
cytometry in cells from the nasal cavity using antibodies that were
shown to detect CFTR in ectopic expression systems. Since we
performed indirect stainings and used isotype-specific secondary
antibodies, we combined mIgG1 anti pan-Cytokeratin with non-
mIgG1 CFTR mAbs and mIgG2a anti-E cadherin with CFTR-
specific mIgG1 mAbs. CFTR-directed mAbs selectively stained
epithelial cells in contrast with isotype control staining. A
representative staining of mAb 24.1 is indicated in Fig. 4A.
Non-epithelial, non-CD45 cells, presumably stromal cells such as
fibroblasts, displayed only limited reactivity. Some immunoreac-
tivity of CFTR mAbs was observed for haematopoietic cells (CD45
positive). We also observed selective staining of epithelial cells
using mAbs 432, 450, 570, 769, L12B4 and 596 (Fig. 4B).
Differences in staining intensity of non-epithelial cells and
epithelial cells were less pronounced for mAb 217 probably due
to aspecific binding. These data suggest that mAb 432, 450, 570,
769, 24.1, L12B4 and 596 are suitable for CFTR detection in
primary nasal epithelial cells by flow cytometry.
Subcellular localization of CFTR in primary human nasal
epithelial cells
To further confirm the staining specificity of the CFTR-directed
mAbs in primary nasal epithelial cells of healthy individuals, we
studied the localization of mAb staining by confocal microscopy.
Staining patterns were analyzed in ciliated columnar epithelial
cells that were selected by differential interference contrast
microscopy. The epithelial origin of cells was indicated by co-
staining with pan-Cytokeratin or E cadherin depending on the
CFTR antibody subclass. Most CFTR antibodies were identified
at the apical membrane and in intracellular organelles, albeit at
variable levels. Two representative examples are indicated for each
antibody in Fig. 5. Staining of the apical surface was detected for
mAb 24.1, L12B4, 217, 596 and 769. MAbs 450 and 570
predominantly stained at intracellular compartments. Nuclear
staining was also observed for mAbs 217, 432, 596 and 769
suggesting non-CFTR specific staining of a nuclear protein or
contaminating mouse Ig since all CFFT mAbs are provided as
diluted ascites fluid. We therefore excluded these antibodies from
further experiments. Collectively, these data suggests that CFTR is
localized at the apical membrane and intracellular compartments
in nasal epithelial cells, and that different CFTR-specific
antibodies preferentially bind to CFTR localized at distinct
subcellular sites.
CFTR expression in nasal epithelium of healthy
individuals and CF patients
To compare CFTR expression levels in healthy individuals and
CF patients we used four CFTR antibodies that were selected
based on their capacity to detect CFTR by flow cytometry in
ectopic-CFTR expressing cells and nasal epithelium, and by low
nuclear staining. For both healthy controls and CF patients we
observed CFTR-specific staining of pan-Cytokeratin positive cells
as indicated by isotype control staining (Fig. 6A). Somewhat
reduced staining intensity was observed for CF patients using
Figure 2. Analysis of nasal epithelial cells by flow cytometry. A.
Forward and side scatter analysis (FSC and SSC) of brushed nasal cell
before (left panel) or after fixation (right panel) by flow cytometry. Flow
count beads (blue events, left panel) were used to count cells. In the
right panel, epithelial cells are indicated by green events and
haematopoietic cells by red events. B. Labeling of cellular subpopu-
lations in the nasal cavity. Epithelial cells were stained using IgG1 mAb
pan-Cytokeratin and IgG2a mAb E cadherin, and haematopoietic cells
with CD45. C. Quantification of cell yield and cellular subpopulations in
nasal brushing. Box-and-whiskers plot with five-number summaries,
from 10 different healthy individuals were indicated for amount of
events in the live gate (left bar), the percentage of live gate events
(middle bar) and the percentage of E cadherin positive cells (right bar)
within the live gate.
doi:10.1371/journal.pone.0027658.g002
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observed between MFI of healthy controls and CF cells upon
staining with CFTR-directed antibodies. To better control for
technical variability of CFTR staining intensity of brushings
collected from different persons at different days, we added an
internal control consisting of a small amount of BHK cells
transfected with CFTR and non-transfected control BHK cells in
a 1:1 ratio to each sample. We selected mAb 450 to study CFTR
based on its discriminatory power to detect ectopic CFTR in
BHK cells (representative stainings for a healthy and CF
individual are indicated in Fig. 6B). CFTR expression levels
(MFI) were assessed by comparing the levels of the E cadherin
positive cells with the CFTR-transfected BHK cells (Fig. 6C).
Using this MFI we found significantly reduced CFTR staining in
CF individuals as compared to healthy individuals. Collectively,
our data suggest that CFTR is significantly expressed by CF
Figure 3. Validation of CFTR antibodies for flow cytometry using ectopically CFTR-expressing cells. A. A panel of nine monoclonal CFTR
antibodies was used to stain CFTR in BHK cells ectopically expressing CFTR (grey line) or non-transfected control cells (black dotted line). Cells were
stained intracellularly for CFTR, indicated by DyLight 649 conjugated goat anti-mouse antibody. Serial dilutions were performed and one of three
representative experiments is shown. B. Paired analysis of CFTR detection by flow cytometry and Western blot using anti-CFTR mAb 450. Wild type
CFTR or F508del–transduced CFBE41o¯ cells were transfected with CFTR siRNA or scrambled siRNA and evaluated for CFTR protein expression after
48 hours by flow cytometry (left panel; mean 6 SEM; n=3) and Western blot (right panel). HSP 90 was used as a loading control.
doi:10.1371/journal.pone.0027658.g003
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F508del/ nonsense mutation) but at lower levels than healthy
controls.
Discussion
Here, we describe a novel procedure to study CFTR expression
in small amounts of primary human nasal epithelial cells using
flow cytometry. We demonstrated that CF patients express
significant total levels of CFTR protein, although reduced
compared to healthy controls. Flow cytometric analysis of relative
CFTR expression levels offers important advantages over
conventional approaches to study CFTR expression in patient
materials. Thus far, most data has been generated by preparing
cell lysates from which CFTR mRNA and protein is analyzed as
we did in Fig. 1. Importantly, these techniques do not indicate the
differences in CFTR expression of individual cells. In contrast,
flow cytometric analysis allowed us to study the cellular
composition of nasal brushings and relative CFTR expression
levels of various subpopulations in an unbiased fashion (Fig. 2, 3,
4). Other advantages of flow cytometry over Western blotting are
the low cell numbers required for analysis, short procedures, and
the absence of enzymatic procedures to detect CFTR-bound
antibodies. The considerable variation in the amount of leukocytes
present in different nasal brushings also implies that CFTR
expression analysis by Western blotting requires normalization for
lower CFTR expressing cell subsets such as leukocytes. Further-
more, proteases present in leukocytes such as neutrophils can
degrade CFTR in cell lysates, even in the presence of various
protease inhibitor cocktails (data not shown).
Figure 4. CFTR detection in human nasal epithelial cells by flow cytometry. A. Nasal cells were intracellularly stained using CFTR mAb 24.1
and pan-Cytokeratin and two subclass-specific secondary Abs conjugated to DyLight 488 and DyLight 649. CD45-Pecy7 staining was performed to
visualize haematopoietic cells. The left panel shows isotype control staining for the CFTR mAb, the middle panel shows CFTR staining, and the right
panel a histogram of CFTR staining intensities for non-pan-Cytokeratin non-CD45 cells (grey), CD45+ cells (red), and pan-Cytokeratin positive cells
(blue). B. Intracellular staining for CFTR using multiple CFTR-directed mAbs. Histograms are shown that indicate CFTR staining intensity (or
representative isotype control) of epithelial cells gated by E cadherin or pan-Cytokeratin (black line) and non-epithelial non-CD45 positive cells (grey).
A representative example out of three is shown.
doi:10.1371/journal.pone.0027658.g004
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addressed in current literature, we compared a panel of nine
monoclonal CFTR antibodies. Differences in CFTR localization
for different antibodies observed by confocal microscopy could be
explained by epitope blocking due to interacting proteins present
at specific cellular compartments. Other- groups also investigated
CFTR staining specificity of various CFTR-directed mAbs by
immunofluorescence [9–11,17]. In general, similar staining
patterns could be observed. In contrast to previous studies we
demonstrated L12B4 staining at the apical region instead of in
intracellular structures similar in morphology and structure to the
Golgi apparatus [17,18]. This could be explained by the different
fixation methods used and different antibody batches as we
observed for L12B4. CFTR-specific antibodies preferentially bind
to CFTR localized at distinct subcellular sites.
In our study we found that CFTR expression levels were lower in
CF patients as compared to in healthy individuals and these
differencesreachedstatisticalsignificance whenaninternal standard
was used to correct for variation in staining intensity between
brushings obtained at different days. These data are in concordance
with earlier findings that indicated that considerable CFTR levels
are expressed in airway epithelial cells in CF patients [9–11,17,19].
Figure 5. Immunolocalization of CFTR in nasal epithelial cells. Confocal analysis of CFTR in nasal epithelial cells of healthy individuals, two
representative examples for all CFTR mAbs are shown. CFTR mIgG2 subclasses 24.1, L12B4, and 596 (green) were simultaneously stained with pan-
Cytokeratin (red). CFTR mIgG1 subclass antibodies 217, 432, 450, 570 and 769 (red) were stained with E cadherin. Nuclei were indicated by dapi
staining. The right panel shows a merge of all stainings.
doi:10.1371/journal.pone.0027658.g005
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relation between CFTR expression and patient-specific disease
course. Considerable variation in staining intensity was observed
within homozygous F508del patients that may associate with
differences in residual CFTR function and clinical phenotype.
Measurement of apically-located CFTR is presumably more
important for associations between CFTR protein expression
and clinical phenotype and may be developed using our procedure
to generate single epithelial cells from brushings followed by
sophisticated image analysis techniques. The generation of novel
Figure 6. CFTR expression levels in nasal epithelial cells obtained from healthy individuals and CF patients. A. CFTR expression levels
in nasal epithelial cells were assessed by flow cytometry with four CFTR mAbs of multiple healthy persons and CF patients. CFTR expression levels are
indicated by mean fluorescent intensity (MFI). Staining with a mIgG1 CFTR mAb 450, 570 isotype control are indicated in the left panel, whereas
mIgG2a CFTR mAbs L12B4 and 24.1 compared to isotype control are indicated in the right panel. Average 6 SEM are shown. B. Representative
example of CFTR staining on a healthy or CF individual including an internal standard. Aliquots of frozen BHK cells transfected with or without CFTR
mixed at 1:1 ratio, and pre-labeled with Hoechst were thawed and added to nasal epithelial cells prior to E cadherin and CFTR staining. Hoechst-
positive CFTR-BHK cells (blue) and BHK cells (grey), and E cadherin positive cells (red) were gated and represented in dot plots showing Hoechst and
CFTR staining (left panel) and represented in a histogram (right panel). C. Ratio of CFTR levels of E cadherin positive cells and CFTR-transfected BHK
cells determined for 5 CF individuals and 9 healthy controls. Data represent average 6 SEM.
doi:10.1371/journal.pone.0027658.g006
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 12 | e27658CFTR antibodies directed against extracellular epitopes would
also be an important addition. Further optimization of this
procedure may also be important for monitoring of CFTR-
directed pharmacotherapy such as CFTR correctors, and
identification of novel biomarkers. Furthermore, studying CFTR
expression in different epithelial subsets using markers specific for
ciliated, basal or goblet cells could be used to more selectively stain
high CFTR expressing cells.
In conclusion, we developed a novel procedure to generate
single cells from nasal brushings that can by analyzed by flow
cytometry. It is a relatively quick and simple procedure and cell
yields are sufficient to study protein expression levels of various
subsets of cells present in the nasal cavity. Here we studied CFTR
protein expression in healthy individuals and CF patients and
found the latter to express lower levels of CFTR. In general, our
procedure may be used to study protein expression in nasal
epithelium in an unbiased fashion in patients that have altered
airway epithelium such as asthma, chronic obstructive pulmonary
diseases and cystic fibrosis.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The Study was approved by the
Medical Research Ethics Committee of the UMC Utrecht, Ref 10-
095. All participants provided written informed consent for the
collection of samples and subsequent analysis.
Cell lines
Calu-3 cells, a human lung adenocarcinoma cell line,
endogenously expressing CFTR (ATCC, Manassas, VA) and
baby hamster kidney cells (BHK, courtesy of Dr. Ineke Braakman,
Utrecht University, The Netherlands) were grown in DMEM
containing 10% fetal calf serum. CFTR-transfected BHK cells
were grown in the presence of methotrexate 5 mM (Pharma-
chemie, Haarlem, The Netherlands). Human bronchial epithelial
cells (CFBE41o¯), derived from a CF patient and stably transduced
with wild type CFTR or the DF508 mutation, were grown as
described (courtesy of Dr. B.A. Stanton, Dartmouth Medical
School, NH) [20].
All cell lines were cultured in media containing penicillin
(100U/ml) and streptomycin (100 mg/ml) and kept in humidified
incubators at 37uC containing 5% CO2. Cell culture media and
reagents were obtained from Invitrogen (Carlsbad, CA).
Human nasal epithelial cells
Nasal epithelial cells from healthy volunteers or CF patients
were collected as described [16]. Cytological brushes were
obtained from cell tip (Servoprax, Wesel, Germany). Cells were
collected in DMEM and centrifuged at 800xg for 5 min, at 4uC.
Thereafter resuspended in PBS and EDTA 5 mM for 15 minutes,
and filtered through cup Filcons 50 mm (BD, San Jose, CA) to
generate single cell suspensions. Cells were counted by flow
cytometry using flow-count beads (Beckman-Coulter, Brea, CA).
Primary antibodies
The following CFTR-specific antibodies were used: monoclonal
antibody (mAb) 24-1 (mouse IgG2a) (R&D systems, Minneapolis,
MN), mAb L12B4 (mIgG2a) (Chemicon international; Temecula,
CA) and mAb M3A7 (mIgG1) (Chemicon International). The
following antibodies were obtained via the Cystic Fibrosis
Foundation Therapeutics (www.cftrfolding.org/CFFTReagents.
htm) and were generously provided by Dr. J. Riordan (Depart-
ment of Biochemistry and Biophysics and Cystic Fibrosis Center of
North Carolina at Chapel Hill, NC); mAbs 217, 432, 450 and 570
(mIgG1) [12,21–24], 596 (mIgG2b) [12,21–24] and 769 mAb
(mIgG1) [12,24]. Other antibodies used in this study were mIgG1
mAb anti pan-Cytokeratin (Santa Cruz, CA), mAb mIgG2a anti-E
cadherin (Beckton Dickinson, NJ) and FITC-conjugated mouse
anti-EGF receptor (Becton Dickinson). Mouse anti-human CD45-
PeCy7 (BD). The rabbit serum against Hsp90 was purchased from
Ineke Braakman, Utrecht University, The Netherlands.
RNA isolation, cDNA synthesis and real-time quantitative
RT-PCR
RNA was extracted from nasal epithelial cells by RNAeasy
columns (Qiagen, Hilden, Germany), according to the manufac-
turer’s protocol. Thereafter total RNA was reverse-transcribed
into cDNA using I script cDNA synthesis kit (Bio-Rad, Hemel
Hempstead, UK). Real-time PCR was performed and quantified
with a SYBR Green containing PCR mix (Bio-Rad). CFTR was
amplified using forward primer GGACAGTTGTTGGCGG-
TTGC and reverse primer CTTGGAGATGTCCTCTTCTAG
TTG as previous described [25]. Human b2-microglobulin
(forward primer ATGAGTATGCCTGCCGTGTGA and reverse
primer GGCATCTTCAAACCTCCATG) was amplified as
control for cDNA synthesis and input. The PCR conditions were
as follows: one cycle for 3 min at 95uC, 40 cycles of 30 sec at
95uC, 30 sec at 60uC and 30 sec at 72uC), 1 min at 95uC and for
1 min at 65uC. PCR products were analyzed using 1% agarose gel
electrophoresis and ethidium bromide.
Western blot analysis
Cell lysis, protein quantification and Western blot analysis was
performed as described but with minor adaptations [26].
Collected nasal cells were lysed in Laemmli buffer in the
presence of protease inhibitor cocktail (HALT, Thermo scientific,
Rockford, IL), incubated for 30 min at 37uC, and passed through
a 25G needle to reduce viscosity. Protein samples were
quantified, separated on a 6% SDS-polyacrylamide gel, and
transferred onto PVDF membrane. Membranes were blocked
using milk protein, and probed with CFTR antibody 24.1 and
EGFR as loading control. These were visualized by horseradish
peroxidase-conjugated secondary antibody (Dako,Glostrup, Den-
mark), enhanced chemiluminiscent and films (Fuji Medical X-ray
film, Tokyo, Japan).
Intracellular staining
Cells were fixed with 50 ml Cytofix (BD pharmingen, San Jose ´,
CA) per 5610
4 cells for 30 min at 4uC as all further steps. Next,
cells were washed twice with Perm Wash buffer (BD) and
incubated with 10% goat serum for 15 min in the same buffer.
Subsequently, cells were incubated for 45 min with mIgG2a anti-
E cadherin and mIgG1 anti-CFTR antibodies, or mIgG1 anti
pan-Cytokeratin and mIgG2a/b anti CFTR for concentrations
indicated. Cells were washed twice and incubated for 30 min with
secondary antibodies at 1 mg/ml: goat anti-mouse IgG1 Dylight
649-conjugated and goat anti- mouse IgG2a Dylight 488 (Jackson
Immuno Research, West Grove, PA). Cells were washed in Perm
Wash buffer and resuspended in PBS containing 0.2% FCS and
0.1% sodium azide. Subsequently, cells were analyzed by flow
cytometry using a FACS Canto (BD) or confocal microscopy using
a Zeiss LSM710 and 63x objective (Zeiss, Heidelberg, Germany)
after spinning cells on microscope glasses and embedding in
Mowiol containing Dapi (49,6-diamidino-2-phenylindole, Sigma)
as described [27].
CFTR Expression by Flow Cytometry
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Four pre- designed siRNAs for CFTR were purchased (#1
GAACACAUACCUUCGAUAU; #2GUACAAACAUGGUAU-
GACU; #3GUGAAAGAC UUGUGAUUAC; #4GCAG-
GGGAUUCUUAAUA) (Thermo Fisher scientific, Lafayette,
CO). Transfection with a non-targeting pool of siRNA (Thermo
Fisher Scientific) was used as control. CFBE41o ¯ cells stably
transduced with either WT-CFTR or F508del CFTR were seeded
in 10 cm
2 dishes and transfected at 60% confluence with 20 nM
siRNA using Lipofectamine RNAiMAX (Invitrogen) according to
the manufacturer’s instructions. CFTR analysis by flow cytometry
and Western blot was performed 48h post transfection.
Statistical analysis
Statistical analysis was assessed using a Student’s t-test, and
significance was accepted at p,0.05. All statistical analyzes were
performed using Prism statistical software version 5 (Graph Pad,
La Jolla, CA).
Supporting Information
Figure S1 Validation of the CFTR antibodies for flow
cytometry in a cell line. Paired analysis of CFTR detection by
flow cytometry and Western blot using anti-CFTR mAbs 570, 769
and 24.1. Wild type CFTR or F508del–transduced CFBE41o¯
cells were transfected with CFTR siRNA or scrambled siRNA and
evaluated for CFTR protein expression after 48 hours by (A) flow
cytometry (mean 6 SEM; n=3) and (B) Western blot. HSP 90 was
used as a loading control.
(TIF)
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